This study investigates an investigational treatment for individuals with diabetes. Diabetes is a condition where the body has difficulty managing blood sugar levels, which can lead to various health issues if not properly managed.Participants in this study will receive either the investigational treatment or a placebo. A placebo is an …
Who can participate: Participants aged [age range] with a diagnosis of [Condition] may be eligible for this study. Key eligibility factors include [list key criteria].Study details: Participants will receive the investigational treatment and undergo [types of procedures, tests, or assessments] to monitor [specific outcomes].
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in people who have had a lung transplant. The purpose is to see if the investigational medication can help with a condition called CLAD, which stands for chronic lung allograft dysfunction. CLAD is a problem …
This study investigates the effects of an investigational medication in people with primary progressive multiple sclerosis (PPMS). PPMS is a type of multiple sclerosis (MS) that causes a gradual worsening of symptoms without relapses. The aim is to see if the investigational medication can delay the progression of disability compared …
This study investigates an investigational medication combined with other agents to treat relapsed or refractory myeloma, a type of blood cancer. Myeloma affects plasma cells in the bone marrow and can cause bone pain, fatigue, and increased risk of infections. The study includes multiple substudies to explore different combinations and …
This study investigates an investigational medication for adults with moderate to severe atopic dermatitis (AD). Atopic dermatitis is a condition that causes red, itchy skin. This study aims to understand the safety and effectiveness of the investigational medication in participants who have already been part of a previous trial involving …
This study investigates the long-term safety and effects of an investigational medication in people aged 12 and older with moderate to severe atopic dermatitis (AD). Atopic dermatitis, also known as eczema, is a condition that makes the skin red, inflamed, and itchy. The purpose of this study is to understand …
This study investigates the treatment of moderate to severe atopic dermatitis (AD), a skin condition causing itchy, inflamed skin. The purpose is to assess how effective and safe a solution for injection is compared to a placebo in people aged 12 and older with AD that is not well controlled …
This study investigates the effectiveness of an investigational medication in delaying the progression of disability in people with non-relapsing secondary progressive multiple sclerosis (nrSPMS). Multiple sclerosis (MS) is a condition where the immune system mistakenly attacks the protective covering of nerves, leading to communication problems between the brain and the …
This study investigates the safety and ability to produce antibodies of an investigational pneumococcal conjugate vaccine, known as PCV21, in healthy infants. Antibodies are proteins in the blood that the body uses to fight infections. The study compares PCV21 to an existing 20-valent pneumococcal vaccine when both are given with …
